(19)
(11) EP 1 514 106 A1

(12)

(43) Date of publication:
16.03.2005 Bulletin 2005/11

(21) Application number: 03736779.4

(22) Date of filing: 29.05.2003
(51) International Patent Classification (IPC)7G01N 33/53, A01N 37/18, A61K 38/00, C07K 1/00, C07K 2/00, C07K 4/00, C07K 5/00, C07K 7/00, C07K 14/00, C07K 16/00, C07K 17/00
(86) International application number:
PCT/US2003/017211
(87) International publication number:
WO 2003/102583 (11.12.2003 Gazette 2003/50)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR
Designated Extension States:
AL LT LV MK

(30) Priority: 29.05.2002 US 384452 P
05.06.2002 US 386019 P
06.09.2002 US 408816 P
16.10.2002 US 272531
06.02.2003 US 445734 P

(71) Applicant: ZyStor Therapeutics , Inc.
Milwaukee, Wisconsin, 53202 (US)

(72) Inventors:
  • LEBOWITZ, Jonathan, H.
    Frontenac, MO 63131 (US)
  • BEVERLEY, Stephen, M.
    Clayton, MO 63105 (US)
  • SLY, William, S.
    St. Louis, MO 63130 (US)

(74) Representative: Chapman, Paul William et al
Kilburn & Strode,20 Red Lion Street
London WC1R 4PJ
London WC1R 4PJ (GB)

   


(54) TARGETED THERAPEUTIC PROTEINS